8-K Reg FD – Taysha Gene Therapies, Inc. (0001806310) June 29
Item 7.01 Regulation FD Disclosure. On June 29, 2021, Taysha Gene Therapies, Inc. (the “Company”) will host the second day of a two-day virtual research and development day (the “R&D Day”) for analysts and investors to highlight the Company’s research and development progress, focused on advancement of its early- and late-stage investigational programs. A copy…
Read More “8-K Reg FD – Taysha Gene Therapies, Inc. (0001806310) June 29” »